EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies

Henriett Butz iD, Viktória Vereczki, Barna Budai iD, Gábor Rubovszky iD, Rebeka Gyebrovszki, Ramóna Vida, Erika Szőcs, Bence Gerecs, Andrea Kohánka iD, Erika Tóth iD, István Likó iD, Imre Kacskovics iD und 1 weitere

International Journal of Molecular Sciences · 03.11.2024 · 25 (21) · 11813

DOI: 10.3390/ijms252111813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.11.2024. Verfasst von Henriett Butz und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, The National Tumour Biology Laboratory, Comprehensive Cancer Centre, National Institute of Oncology, 1122 Budapest,…. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Protein Isoforms, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research, Development and Innovation Office, New National Excellence Program of the Ministry of Human Capacities, Hungarian Academy of Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucocorticoid receptor (GR) activation may promote metastasis in oestrogen receptor-negative and triple-negative breast cancer (TNBC). However, the role of the GRβ isoform, which has opposing effects to the main isoform, has not been studied in clinical samples. We aimed to analyse the intracellular localisation of total GR and GRβ in vitro using plasmid constructs and fluorescent immunocytochemistry. Additionally, our goal was to perform immunostaining for total GR and GRβ on two cohorts: (i) on 194 clinical breast cancer samples to compare the expression in different molecular subtypes, and (ii) on 161 TNBC samples to analyse the association of GR with survival. We supplemented our analysis with RNA data from 1097 TNBC cases. We found that in the absence of the ligand, GR resided in the cytoplasm of breast cancer cells, while upon ligand activation, it translocated to the nucleus. A negative correlation was found between cytoplasmic GRtotal and Ki67 in luminal A tumours, while the opposite trend was observed in TNBC samples. Tumours with strong lymphoid infiltration showed higher cytoplasmic GRtotal staining compared to those with weaker infiltration. Patients with high nuclear GRtotal staining had shorter progression-free survival in univariate analysis. High cytoplasmic GRβ was a marker for better overall survival in multivariate analysis (10-year overall survival HR [95% CI]: 0.46 [0.22–0.95], p = 0.036). As a conclusions, this study is the first to investigate GRβ expression in breast tumours. Different expression and cellular localisation of GRtotal and GRβ were observed in the context of molecular subtypes, underscoring the complex role of GR in breast cancer. An inverse association between cytoplasmic GRtotal and the Ki67 proliferation index was observed in luminal A and TNBC. Regarding the impact of GR on outcomes in TNBC patients, while cytoplasmic GRβ was associated with a better prognosis, patients with nuclear GRtotal staining may be at a higher risk of disease progression, as it negatively affects survival. Caution should be exercised when using glucocorticoids in patients with nuclear GR staining, as it may negatively impact survival.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GlucocorticoidProtein IsoformsTriple Negative Breast NeoplasmsHumansFemaleMiddle AgedBreast NeoplasmsBiomarkers, TumorPrognosisCell Line, TumorAdultAgedCell NucleusCytoplasm

Stichwörter der Autor:innen

breast cancerglucocorticoid receptorglucocorticoid receptor βimmunohistochemistryoutcomesurvivaltriple-negative breast cancer

Substanzen

Receptors, GlucocorticoidProtein Isoformsglucocorticoid receptor betaBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Molecular Genetics, The National Tumour Biology Laboratory, Comprehensive Cancer Centre, National Institute of Oncology, 1122 Budapest, Hungary.
  • Department of Oncology Biobank, National Institute of Oncology, Comprehensive Cancer Centre, 1122 Budapest, Hungary.
  • HUN-REN-SU Hereditary Tumours Research Group, Hungarian Research Network, 1089 Budapest, Hungary.
  • Department of Laboratory Medicine, Semmelweis University, 1085 Budapest, Hungary.
  • Department of Anatomy, Histology and Embryology, Semmelweis University, 1085 Budapest, Hungary.
  • Department of Thoracic and Abdominal Tumours and Clinical Pharmacology, National Institute of Oncology, Comprehensive Cancer Centre, 1122 Budapest, Hungary.

ORCID-Profile: Henriett Butz, Barna Budai, Gábor Rubovszky, Andrea Kohánka, Erika Tóth, István Likó, Imre Kacskovics, Attila Patócs

Förderung

  • National Research, Development and Innovation Office
  • New National Excellence Program of the Ministry of Human Capacities
  • Hungarian Academy of Sciences
  • National Tumor Biology Laboratory

Zitieren

APA

Butz, H., Vereczki, V., Budai, B., Rubovszky, G., Gyebrovszki, R., Vida, R., Szőcs, E., Gerecs, B., Kohánka, A., Tóth, E., Likó, I., Kacskovics, I., & Patócs, A. (2024). Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies. International Journal of Molecular Sciences, 25(21), 11813. https://doi.org/10.3390/ijms252111813

Vancouver

Butz H, Vereczki V, Budai B, Rubovszky G, Gyebrovszki R, Vida R, et al. Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies. International Journal of Molecular Sciences. 2024;25(21):11813. doi:10.3390/ijms252111813

BibTeX
@article{Butz2024,
  author = {Butz, Henriett and Vereczki, Viktória and Budai, Barna and Rubovszky, Gábor and Gyebrovszki, Rebeka and Vida, Ramóna and Szőcs, Erika and Gerecs, Bence and Kohánka, Andrea and Tóth, Erika and Likó, István and Kacskovics, Imre and Patócs, Attila},
  title = {Glucocorticoid Receptor Isoforms in Breast Cancer Raise Implications for Personalised Supportive Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {21},
  pages = {11813},
  doi = {10.3390/ijms252111813}
}
Kostenlos starten →